Rudolf Kwan

Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)

Michael Smolinski, Yahao Bu, James L. Clements et al. · Journal of Medicinal Chemistry · 2018 · 97 citations · Full text

Chemoprevention Strategy, Action Src Signaling, Molecular Biology +24

Randomized Controlled Trials of the D1/D5 Antagonist Ecopipam for Weight Loss in Obese Subjects

Arne Astrup, Frank L. Greenway, Walter Ling et al. · Obesity · 2007 · 64 citations · Full text

Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results

Steven Kempers, Janet DuBois, Seth Forman et al. · Journal of Drugs in Dermatology · 2020 · 40 citations

Effects of a Low Carbohydrate Isoenergetic Diet on Sleep Behavior and Pulmonary Functions in Healthy Female Adult Humans

Rudolf Kwan, Susan E. Thomas, M. Afzal Mir · Journal of Nutrition · 1986 · 38 citations

Obesity, Nutrition, Sleep +10

A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies

Aung Naing, Roger B. Cohen, Grace K. Dy et al. · Investigational New Drugs · 2013 · 38 citations

Medicine, Pharmacology, Src Inhibitor +6